Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT00606242 · ClinicalTrials.gov registry record · Phase 4

Dose Response Effects of Inhaled Fluticasone on Airway Effects of Hypertonic-saline in Asthma

A Phase 4 study of Asthma, sponsored by University of California, San Francisco.

Completed
Registry status
Phase 4
Development phase
44
Enrollment target
1
Study location

NCT00606242 is a Phase 4 study of Asthma that has completed, run by University of California, San Francisco. The registered enrollment target is 44 participants, below the 1,563-participant average among 374 other Asthma trials with a reported enrollment target (97% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT00606242, a Phase 4 study of Asthma, has completed, sponsored by University of California, San Francisco.

COMPLETED
Registry status
Phase 4
Development phase
44 participants
Enrollment target
1
Study location

Study Summary

This study investigates the effect of a inhaled corticosteroid (fluticasone or "Flovent") on airway narrowing induced by hypertonic saline (salty water). The study hypothesis is that fluticasone will be more effective in preventing saline-induced airway narrowing than methacholine-induced narrowing.

Conditions Studied

Asthma

Interventions

  • DRUG Fluticasone

Study Locations (1)

California

  • University of California, San Francisco - San Francisco

Trial Details

FieldValue
Enrollment Target 44 participants
Start Date 2000-01
Est. Completion 2007-12
Phase Phase 4

Sponsor

University of California, San Francisco

1,713 total trials

Interested in This Trial?

Full Details on ClinicalTrials.gov ↗

What the Registry Record Tells You About NCT00606242

The ClinicalTrials.gov registry entry for NCT00606242 describes a study currently listed as completed, categorized as Phase 4. The registered enrollment target is 44 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 1,563-participant average among 374 other Asthma trials with a reported enrollment target (97% lower). The listed sponsor is University of California, San Francisco, which has 1,713 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Asthma appearing as the primary indexed condition, and to 1 intervention - of which Fluticasone is the first listed.

NCT00606242 reports 1 study location spanning 1 distinct geographic area - top geographies include California.

Frequently Asked Questions

What is clinical trial NCT00606242 about?

NCT00606242 is a clinical study titled "Dose Response Effects of Inhaled Fluticasone on Airway Effects of Hypertonic-saline in Asthma". This study investigates the effect of a inhaled corticosteroid (fluticasone or "Flovent") on airway narrowing induced by hypertonic saline (salty water). The study hypothesis is that fluticasone will be more effective in preventing saline-induced airway narrowing than methacholine-induced narrowing.

What is the current status of trial NCT00606242?

This trial is currently completed. It is a Phase 4 study. The enrollment target is 44 participants. The study started on 2000-01. Estimated completion is 2007-12.

What conditions does trial NCT00606242 study?

This clinical trial studies the following conditions: Asthma.

What interventions are being tested in trial NCT00606242?

The interventions under investigation include: Fluticasone (DRUG).

Who is sponsoring clinical trial NCT00606242?

This trial is sponsored by University of California, San Francisco, which has 1,713 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT00606242 being conducted?

This trial has 1 study location across California. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Learn More About Clinical Trials

Similar trials for Asthma

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Explore more on PlainTrial

Asthma

All registered trials for this condition

California

All trials with a study site in California

Recruiting now

Find trials open to new participants near you

Rankings

Top sponsors, conditions, and phases

Read our methodology - how this data is sourced, computed, and verified.

Related

Browse all → | Rankings →
Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.